QUIA PHARMA AB
Develops biobetters by enhancing approved drugs with a patented drug delivery platform.
QUIA | ST
Overview
Corporate Details
- ISIN(s):
- SE0020678159
- LEI:
- 967600JUP7EI6X9D2Z44
- Country:
- Sweden
- Address:
- Virdings Allé 32 B, 754 50 Uppsala
- Website:
- https://www.quiapeg.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
QUIA PHARMA AB is a pharmaceutical development company focused on its patented drug delivery platform technology, Uni-Qleaver®. The company's core business is the research, development, and commercialization of this proprietary system, which utilizes a releasable PEGylation technology. QUIA PHARMA's strategy is to apply the Uni-Qleaver® platform to existing, approved drugs to create enhanced and patentable versions (biobetters). By improving the properties of proven therapeutics, the company aims to build a pipeline of valuable drug candidates.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all QUIA PHARMA AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for QUIA PHARMA AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
